Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank J Slack

Showing results (31-40 of 209) with videos related to

Pageof 21
Sort By:
Genome Medicine|December 31, 2013
MicroRNAs and the cancer phenotype: profiling, signatures and clinical implicationsCarlos Stahlhut, Frank J Slack
Developmental Dynamics : an Official Publication of the American Association of Anatomists|February 13, 2010
Developmental biomarkers of aging in Caenorhabditis elegansZachary Pincus, Frank J Slack
Expert Opinion on Drug Discovery|May 19, 2020
Challenges identifying efficacious miRNA therapeutics for cancerMeirav Segal, Frank J Slack
The New England Journal of Medicine|December 19, 2008
MicroRNA in cancer prognosisFrank J Slack, Joanne B Weidhaas
Current Opinion in Molecular Therapeutics|April 8, 2010
Potential microRNA therapies targeting Ras, NFkappaB and p53 signalingAndrea L Kasinski, Frank J Slack
Cell Cycle (Georgetown, Tex.)|August 23, 2008
microRNAs and cancer: an overviewPedro P Medina, Frank J Slack
Cancer Journal (Sudbury, Mass.)|June 1, 2012
The duality of oncomiR addiction in the maintenance and treatment of cancerChristopher J Cheng, Frank J Slack
Molecular Therapy. Nucleic Acids|January 25, 2013
Arresting the Culprit: Targeted Antagomir Delivery to Sequester Oncogenic miR-221 in HCCAndrea L Kasinski, Frank J Slack
Bio-Protocol|May 31, 2016
Generation of Mouse Lung Epithelial CellsAndrea L Kasinski, Frank J Slack
Journal of Cancer Metastasis and Treatment|July 2, 2021
Multi-layered control of PD-L1 expression in Epstein-Barr virus-associated gastric cancerChristos N Miliotis, Frank J Slack
Pageof 21

Showing results (31-40 of 209) with videos related to

Sort By:
Pageof 21
Genome Medicine|December 31, 2013
MicroRNAs and the cancer phenotype: profiling, signatures and clinical implicationsCarlos Stahlhut, Frank J Slack
Developmental Dynamics : an Official Publication of the American Association of Anatomists|February 13, 2010
Developmental biomarkers of aging in Caenorhabditis elegansZachary Pincus, Frank J Slack
Expert Opinion on Drug Discovery|May 19, 2020
Challenges identifying efficacious miRNA therapeutics for cancerMeirav Segal, Frank J Slack
The New England Journal of Medicine|December 19, 2008
MicroRNA in cancer prognosisFrank J Slack, Joanne B Weidhaas
Current Opinion in Molecular Therapeutics|April 8, 2010
Potential microRNA therapies targeting Ras, NFkappaB and p53 signalingAndrea L Kasinski, Frank J Slack
Cell Cycle (Georgetown, Tex.)|August 23, 2008
microRNAs and cancer: an overviewPedro P Medina, Frank J Slack
Cancer Journal (Sudbury, Mass.)|June 1, 2012
The duality of oncomiR addiction in the maintenance and treatment of cancerChristopher J Cheng, Frank J Slack
Molecular Therapy. Nucleic Acids|January 25, 2013
Arresting the Culprit: Targeted Antagomir Delivery to Sequester Oncogenic miR-221 in HCCAndrea L Kasinski, Frank J Slack
Bio-Protocol|May 31, 2016
Generation of Mouse Lung Epithelial CellsAndrea L Kasinski, Frank J Slack
Journal of Cancer Metastasis and Treatment|July 2, 2021
Multi-layered control of PD-L1 expression in Epstein-Barr virus-associated gastric cancerChristos N Miliotis, Frank J Slack
Pageof 21